US Senate votes to include CBDC ban in bipartisan housing bill
The provision banning the Federal Reserve from issuing a central bank digital currency was included in housing affordability legislation.
BTC
ETH
BNB
ADA
XRP
DOGE
SOL
DOT
BTC
ETH
BNB
ADA
XRP
DOGE
SOL
DOT
BTC
ETH
BNB
ADA
XRP
DOGE
SOL
DOT
BTC
ETH
BNB
ADA
XRP
DOGE
SOL
DOT
Coinbase, Robinhood and Circle are expanding into stablecoins, payments and prediction markets, but their latest earnings show how hard it is to escape cry...
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse Articles
The provision banning the Federal Reserve from issuing a central bank digital currency was included in housing affordability legislation.
A bipartisan housing bill was approved in the Senate, carrying an unrelated ban on U.S. central bank digital currencies, but its future remains uncertain.
Futures rose amid a reported plan for a record release of crude oil reserves. Oracle jumped on earnings late.
Founders of the AI-focused platform will join Meta's research team, following a recent trend of industry acquisitions.
The European Central Bank has launched Appia to guide Europe's tokenized financial ecosystem anchored in central bank money, with early Pontes pilots plann...
Campbell's cuts annual forecasts amid macroeconomic pressures
Nvidia has delivered a win for investors over time.
AppLovin Corporation (NASDAQ:APP) is one of the stocks on which Jim Cramer expressed his thoughts. A caller asked if the "AI ad platform" is still alive, a...
Oracle Corporation (NYSE:ORCL) is one of the stocks on which Jim Cramer expressed his thoughts. Cramer highlighted the company's data center business, as h...
Serve Robotics stock jumps on White Castle delivery deal
Where the S&P 500 goes next is clearly hinging on oil prices and the Strait of Hormuz. Here's a fresh line in the sand.
Once lucrative for insurers and a safe haven for patients, Medicare Advantage is getting squeezed.